Raphael Pharmaceutical Stock Analysis
| RAPH Stock | 1.40 0.00 0.00% |
Raphael Pharmaceutical's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Raphael Pharmaceutical's financial risk is the risk to Raphael Pharmaceutical stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Raphael Pharmaceutical's debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Raphael Pharmaceutical is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Raphael Pharmaceutical to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Raphael Pharmaceutical is said to be less leveraged. If creditors hold a majority of Raphael Pharmaceutical's assets, the OTC Stock is said to be highly leveraged.
Raphael Pharmaceutical is overvalued with Real Value of 1.24 and Hype Value of 1.4. The main objective of Raphael Pharmaceutical otc analysis is to determine its intrinsic value, which is an estimate of what Raphael Pharmaceutical is worth, separate from its market price. There are two main types of Raphael Pharmaceutical's stock analysis: fundamental analysis and technical analysis.
The Raphael Pharmaceutical otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Raphael Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
Raphael |
Raphael OTC Stock Analysis Notes
The company had not issued any dividends in recent years. The quote for Raphael Pharmaceutical is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges.Raphael Pharmaceutical Investment Alerts
| Raphael Pharmaceutical is way too risky over 90 days horizon | |
| Raphael Pharmaceutical may become a speculative penny stock | |
| Raphael Pharmaceutical appears to be risky and price may revert if volatility continues | |
| Raphael Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (1.62 B) with profit before overhead, payroll, taxes, and interest of 0. | |
| Raphael Pharmaceutical generates negative cash flow from operations |
Raphael Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.19 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Raphael Pharmaceutical's market, we take the total number of its shares issued and multiply it by Raphael Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 18th of February 2026, Raphael Pharmaceutical holds the Variance of 124.28, risk adjusted performance of 0.0759, and Coefficient Of Variation of 1193.17. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Raphael Pharmaceutical, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate data for eleven technical drivers for Raphael Pharmaceutical, which can be compared to its competitors.Raphael Pharmaceutical Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Raphael Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Raphael Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Raphael Pharmaceutical Outstanding Bonds
Raphael Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Raphael Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Raphael bonds can be classified according to their maturity, which is the date when Raphael Pharmaceutical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Raphael Pharmaceutical Predictive Daily Indicators
Raphael Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Raphael Pharmaceutical otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Raphael Pharmaceutical Forecast Models
Raphael Pharmaceutical's time-series forecasting models are one of many Raphael Pharmaceutical's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Raphael Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Raphael Pharmaceutical Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Raphael Pharmaceutical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Raphael Pharmaceutical, which in turn will lower the firm's financial flexibility.Raphael Pharmaceutical Corporate Bonds Issued
Most Raphael bonds can be classified according to their maturity, which is the date when Raphael Pharmaceutical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Raphael Pharmaceutical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
| All Next | Launch Module |
Complementary Tools for Raphael OTC Stock analysis
When running Raphael Pharmaceutical's price analysis, check to measure Raphael Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raphael Pharmaceutical is operating at the current time. Most of Raphael Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Raphael Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raphael Pharmaceutical's price. Additionally, you may evaluate how the addition of Raphael Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |